- Gliflozin and blood pressure2014 | First Faculty of Medicine
- Gliflozins and heart failure - what is and will be new?2021 | First Faculty of Medicine
- Protracted effect of gliflozin as a cause of diabetic ketoacidosis during fasting2022 | Faculty of Medicine in Pilsen
- Fournier's gangrene and gliflozins in therapy of diabetes mellitus2019 | Second Faculty of Medicine, Third Faculty of Medicine
- Additional options in diabetes treatment - gliflozins2014 | Faculty of Medicine in Hradec Králové
- Gliflozins and treatment of diabetes2016 | Second Faculty of Medicine
- Gliflozines: inhibitors of SGLT 22013 | Second Faculty of Medicine
- Gliflozins - a new therapeutic strategy for heart failure in patients with diabetes2020 | Second Faculty of Medicine
- Gliflozins: already checked choice for type 2 diabetics2018 | First Faculty of Medicine
- Gliflozins in heart failure treatment or How antidiabetics are changing cardiology2020 | First Faculty of Medicine
- Kidney and the treatment of diabetes: current knowledge and future prospects of the therapy with gliflozines2016 | First Faculty of Medicine, Third Faculty of Medicine
- Gliflozins - part of modern diabetes treatment2015 | Faculty of Medicine in Hradec Králové
- Current position of SGLT2 inhibitors (gliflozins) in the treatment of diabetes mellitus2018 | Second Faculty of Medicine
- Chronic cardiorenal syndrome and gliflozins - a cardiologist's view2023 | First Faculty of Medicine
- Complex effects of gliflozins on cardiovascular systém of diabetic patients2016 | First Faculty of Medicine
- Gliflozins in the treatment of type 1 diabetes mellitus2020 | Faculty of Medicine in Hradec Králové
- How we indicate oral antidiabetics today (from metformin to gliptins and gliflozins)2014 | First Faculty of Medicine
- SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure2021 | First Faculty of Medicine
- Profile of patient with optimum indication for therapy with gliptins, pioglitazone and gliflozins2017 | Second Faculty of Medicine
- News in the treatment of heart failure - gliflozins in patients with a mildly reduced and preserved ejection fraction2023 | First Faculty of Medicine
- Gliflozins slow down the progression of diabetic kidney disease2017 | First Faculty of Medicine
- Renoprotective effects of SGLT2 inhibitors - gliflozins2021 | First Faculty of Medicine
- Non-glycemic effects of gliflozins and their use in practice2020 | First Faculty of Medicine
- Gliflozins in patients with heart failure - expectations and reality2022 | First Faculty of Medicine
- Gliflozin as a key oral hypoglycaemic agent to control type 2 diabetes in a patient with a history of ischaemic heart disease and heart failure2021 | Second Faculty of Medicine, Third Faculty of Medicine
- Diabetes mellitus and gynecological infections2015 | First Faculty of Medicine
- Expert consensus on the practical aspects of the cooperation of cardiologist and diabetologist in the management of the patients with chronic heart failure and reduced ejection fraction +12021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Use of new antidiabetics in lowering the cardiovascular risk2013 | Faculty of Medicine in Hradec Králové
- Expert consensus on the practical aspects of collaboration between cardiologists and diabetologists in the management of patients with chronic heart failure with reduced ejection fraction2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine